Navigation Links
Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
Date:5/16/2011

>

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL, the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

About EXPAREL™

EXPAREL is Pacira's proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam®, both of which are currently used separately in FDA-approved products. Bupivacaine is a well-characterized anesthetic/analgesic that has an established safety profile with more than 20 years of use in the United States. Market data indicate that there is an unmet medical need for a longer-acting anesthetic/analgesic for postsurgical pain management. Several Phase 2 and Phase 3 clinical trials have been completed for EXPAREL and suggest statistically significant reduction of pain in soft tissue and orthopedic surgery in different surgical models. Clinical data from Phase 3 trial 316 suggests that EXPAREL provides analgesia for up to 72 hours post-surgery, the primary endpoint for the trial. The safety of EXPAREL was evaluated in 10 randomized, double-blind, local adm
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
2. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
3. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
4. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
6. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
7. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
8. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
9. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
10. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
11. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 Edwards ... the science of heart valves and hemodynamic monitoring, today announced ... company,s Board of Directors. "Bob is an ardent ... been a true privilege to have him on Edwards, board ... A. Mussallem , Edwards, chairman and CEO.  "Bob has provided ...
(Date:7/30/2015)... Calif. , July 30, 2015 IRIDEX ... will release its second quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... human-animal hybrids to generate stem cells WORCESTER, Mass., ... Sheets: ACTC) and its collaborators reported today that human ... adult human cells. The research, which appears online ahead ... Cells (Editor-in-Chief: Sir Ian Wilmut; published by Mary ...
... Robert C. Gallo Foundation for AIDS and Virus ... as director of international relations. The foundation ... internationally known for expertise in HIV prevention, treatment ... producing groundbreaking HIV research."It is an honor to ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research 2
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... in Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts the ...
(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, ... has re-branded their social media profiles to better connect with the public. The ... communicate, find information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge ...
(Date:7/31/2015)... ... ... to the article published July 27 on My News LA, a fire that ... the city’s fire department before it caused major damage throughout the building. The article also ... it was a fire alarm system that tipped off fire fighters so they could arrive ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... readers and potential patients alike on various plastic surgery procedures including, but not ... include such popular dermatology procedures like Botox and fillers. , Staying up ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2
... N.J., Nov. 10 The New Jersey Hospital Association has ... them protect patients, staff and visitors from H1N1 influenza. , ... for spreading infection in both inpatient and outpatient areas. The ... the age of 18. No individuals under the age ...
... 10 Reportlinker.com announces that a new market ... US World Nutraceutical Ingredients Industry ... Global demand to advance 6.2% annually through ... worldwide is projected to advance 6.2 percent annually ...
... 10 Reportlinker.com announces that a new ... catalogue. , Cancer Non-Hodgkin Lymphoma ... , Life Science Analytics, Cancer Non-Hodgkin ... drug pipeline. This report provides insight into ...
... 10 Reportlinker.com announces that a new ... catalogue. , Ophthalmology and Optometry ... http://www.reportlinker.com/p0161962/Ophthalmology-and-Optometry-Macular-Degeneration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Life Science Analytics, ... information on the current drug pipeline. This ...
... is available in Spanish . , A research team ... presence of the parasite Anisakis spp in anchovies of the ... insist on freezing or cooking fish before consuming it. Although restaurants ... the hours at -20 C", say the UGR scientists, who ...
... lot to do with the foods you eat. To ... healthy meals, the National Heart, Lung, and Blood Institute (NHLBI) ... the Beat Recipes: Deliciously Healthy Dinners. The new cookbook ... Mediterranean, and American cuisine that are good for your heart ...
Cached Medicine News:Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 2Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 3Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 4Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 5Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 6Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 7Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 8Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 9Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 10Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 11Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 12Health News:Reportlinker Adds US World Nutraceutical Ingredients Industry 13Health News:Reportlinker Adds Cancer Non-Hodgkin Lymphoma 2Health News:Reportlinker Adds Ophthalmology and Optometry Macular Degeneration 2Health News:Anisakiasis hazard varies depending on the origin of the fish, according to a study 2Health News:NHLBI publishes new heart healthy cookbook 2
... internal drainage from the ureteropelvic ... sterile in peel-open packages. Intended ... evaluation is advised; polyurethane, C-Flex, ... remain indwelling more than six ...
Used for stenting the urethra during hypospadias or epispadias repair and to allow post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter or instrument introduction. ... to be peeled away and removed. ... or instrument to be introduced should ... through the sheath. Supplied sterile in ...
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: